Harbour's Appointment Bolsters Radicle's Strategic Focus on
Regulatory Compliance and Innovation in Dietary Supplement
Research.
SAN DIEGO, May 7, 2024 /PRNewswire/ -- Radicle
Science, award-winning healthtech B-corp and
Proof-as-a-Service pioneer, proudly announces the appointment of
Pamela Jones Harbour, the first African-American female
Commissioner of the United States Federal Trade Commission (FTC),
to its Strategic Advisory Board. Harbour's addition underscores
Radicle Science's deep commitment to innovative research and
regulatory compliance for the dietary supplement industry.
Harbour's expertise in regulatory and consumer protection law
comes at a critical time as the dietary supplement industry
navigates evolving expectations. In December of 2022, the FTC
released updated Health Products Compliance Guidance, the
organization's first update in 25-years to guide the dietary
supplement industry, clarifying "competent and reliable scientific
evidence" requirements for the substantiation of health
claims. Changing consumer expectations add to the industry
pressure, with McKinsey's 2024 Future of Wellness
Survey stating "Efficacy and scientific credibility are two of
the most important factors for consumers when selecting wellness
products."
"I am honored to join Radicle Science at a time when regulatory
and market forces have rendered proof of effectiveness a 'must
have' for dietary supplements and other wellness products,"
remarked Harbour. "Not only does Radicle's transformative
Proof-as-a-Service approach provide gold-standard clinical evidence
that aligns with expectations from the FDA, FTC, consumers, and
healthcare providers, but the large scale and the diversity of
their study populations pave the path towards personalized
treatments for the population at large. That's the kind of
health equity I am thrilled to be a part of creating."
Radicle Science has been conducting some of history's largest
rigorous clinical trials on dietary supplements, with publications
in peer-reviewed journals such as the Journal of the American
Nutrition Association and Nutrients. Since launching in 2021,
the B-corp has studied 50,000+ diverse Americans, 3 times more than
all participants in NIH-funded phase 3 trials during the same
time. Moreover, the large scale of the Radicle Science
clinical trials enables highly diverse study populations, including
those traditionally underrepresented in clinical trials.
Women are equally represented. Minorities comprise 20-30% of
Radicle's study participants - a contrast to 3.95% minority
inclusion in all trials in the US. Reflecting the US
Census, 20% of Radicle study participants live in rural areas who
would otherwise have limited access to trials.
Dr. Jeff Chen, Co-founder and CEO of Radicle Science, expressed
his excitement about Harbour joining the advisory board, stating,
"Pamela Harbour's extensive regulatory expertise is a perfectly
timed addition to our advisory board. We look forward to
collaborating with Pamela to power the dietary supplement industry
with objective, gold-standard clinical evidence of effectiveness to
drive consumer trust across the wellness industry."
Harbour joins the ranks of industry luminaries on Radicle
Science's advisory board, including Peter Diamandis (XPRIZE
founder), Dr. Jonathan Fielding (UCLA's Fielding School of Public
Health), Tom Aarts (Nutrition Business Journal's Cofounder), Joe
Dickson (Whole Foods' former Global Director of Quality Standards),
and Rhona Applebaum (Coca Cola's first Chief Science and Health
Officer).
Learn more about Harbour's inspiring journey and her vision
for the future of dietary supplements in this exclusive
interview.
About Radicle Science:
Radicle Science pioneered the
"Proof-as-a-Service'' category, offering wellness products
history's first easy path to clinically prove their true effects
beyond placebo. Named "World Changing Idea" by Fast
Company, the B-Corp conducts history's largest clinical trials
on supplements and natural products, leveraging an AI-driven,
automated, standardized and virtual approach. The result is
clinical proof at unprecedented affordability, speed and scale
across diverse populations and conditions. Now, any wellness
product can access Proof-as-a-Service throughout their lifecycle to
develop truly effective products, market strong health claims,
increase customer loyalty, and win trust among retailers, doctors,
and investors. Learn more at www.RadicleScience.com.
Media Contact:
Grace Lightfoot
grace@radiclescience.com
(619) 786-7090
View original content to download
multimedia:https://www.prnewswire.com/news-releases/radicle-science-welcomes-former-ftc-commissioner-pamela-jones-harbour-to-strategic-advisory-board-302138367.html
SOURCE Radicle Science